TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT06615102

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Angiotensin II
Description: Intravenous infusion through a central line according to the patient's situation. Once an infusion is established, the dose will be titrated as frequently as every 5 minutes, as needed, depending on the patient's condition and target MAP.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Noradrenalin
Description: Intravenous infusion through a central line according to the patient's situation. Once an infusion is established, the dose will be titrated as frequently as every 5 minutes, as needed, depending on the patient's condition and target MAP.
Study: NCT06614634

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Remotely supervised exercise at home or outdoors
Description: Aerobic and strengthening exercise program at home/outdoors at least three days a week for four weeks using a Polar H9 heart rate monitor and elastic band.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Hospital-based exercise program
Description: The aerobic and strengthening exercise program three days a week for four weeks under supervision in our cardiopulmonary rehabilitation unit.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Cardiovascular risk modification
Description: Psychosocial support for physical activity counselling, heart-healthy diet, referral for smoking cessation and stress management.
Study: NCT04627025

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: apraglutide
Description: Apraglutide is a peptide analogue of GLP-2 under development for treatment of SBS-IF, which acts as a full agonist at the GLP-2 receptor with in vitro potency and selectivity comparable with native GLP-2.
Study: NCT06614634

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cardiovascular risk modification
Description: Psychosocial support for physical activity counselling, heart-healthy diet, referral for smoking cessation and stress management.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Phone calls with reinforcement feedback
Description: Calls once a week that include symptom inquiries and encouraging feedback on exercise logs.
Study: NCT05635669

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Sacral acupoints acupuncture
Description: Before treatment, the participants will be asked to go to the toilet. All treatments will be performed after skin disinfection. As acupuncture needles are inserted, all points will be lifted, twisted, and stabbed to activate the sensation of de qi. The electroacupuncture stimulation lasted for 30 minutes with a continuous wave of 50 Hz and a current intensity of 1 to 5 mA (preferably with the skin around the acupoints shivering mildly without pain). Participants will receive three treatments per week (every other day), each lasting 30 minutes, for a total of 18 sessions over the course of 6 weeks. The follow-up sessions are on week 18, 30, 42 and 54. In this group, paired electrodes from the electroacupuncture apparatus were attached transversely to the needle handles at bilateral Huiyang(BL35) and Zhongliao(BL33) .

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Abdominal acupoints acupuncture
Description: Before treatment, the participants will be asked to go to the toilet. All treatments will be performed after skin disinfection. As acupuncture needles are inserted, all points will be lifted, twisted, and stabbed to activate the sensation of de qi. The electroacupuncture stimulation lasted for 30 minutes with a continuous wave of 50 Hz and a current intensity of 1 to 5 mA (preferably with the skin around the acupoints shivering mildly without pain). Participants will receive three treatments per week (every other day), each lasting 30 minutes, for a total of 18 sessions over the course of 6 weeks. The follow-up sessions are on week 18, 30, 42 and 54. In this group, paired electrodes from the electroacupuncture apparatus were attached to the needle handles respectively at Zhongji(RN3) and one side of Dahe(KI12), as well as Guanyuan(RN4) and another side of Dahe(KI12).

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Alternating acupoints acupuncture
Description: Before treatment, the participants will be asked to go to the toilet. All treatments will be performed after skin disinfection. As acupuncture needles are inserted, all points will be lifted, twisted, and stabbed to activate the sensation of de qi. The electroacupuncture stimulation lasted for 30 minutes with a continuous wave of 50 Hz and a current intensity of 1 to 5 mA (preferably with the skin around the acupoints shivering mildly without pain). Participants will receive three treatments per week (every other day), each lasting 30 minutes, for a total of 18 sessions over the course of 6 weeks. The follow-up sessions are on week 18, 30, 42 and 54. The application of electroacupuncture is the same as Sacral group and Abdominal group.
Study: NCT06613724

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Magnet System, DI Biofragmentable
Description: Anastomoses achieved by magnetic compression.
Study: NCT05531370

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Breathing Retraining
Description: Conforming the real-world setting, all participants will continue standard asthma care, i.e., acute and planned visits at GP or pulmonologist.~BR aims to normalize the inhaled volume, nasal inhalation, exhalation to the resting position of the chest (functional residual capacity, FRC), use of the diaphragm muscle, and to move lower parts of the chest in a frequency of 12-16 per minute. This pattern is initially trained in rest (e.g., side lying or sitting), then during physical activity (e.g., walking). Uncontrolled coughing, frequent yawning or sighing is handled by a suppression technique. Relaxation technique is introduced as a separate activity but to be combined with the breathing pattern method to be used in both resting and as possible during physical activity.
Study: NCT06453109

Intervention type: DEVICE
Group type: OTHER
Intervention: low intensity focused ultrasound (LIFU)
Description: Low-intensity focused ultrasound (LIFU) provides an energy source with millimeter resolution that can be focused anywhere in the brain safely and effectively for non-invasive and transient neuromodulation. LIFU is an important advance and of great significance for brain-mapping efforts, diagnostics, and therapies in neuroscience and particularly promising for addiction therapy as it provides unprecedented non-surgical access to the brain regardless of depth.~Much lower intensities of focused ultrasound (LIFU) are used so that tissue damage does not occur, but neural activity can be modulated. LIFU utilizes acoustic energy at much lower levels to affect tissue by mechanical effects.

Intervention type: DEVICE
Group type: OTHER
Intervention: low intensity focused ultrasound (LIFU)
Description: Low-intensity focused ultrasound (LIFU) provides an energy source with millimeter resolution that can be focused anywhere in the brain safely and effectively for non-invasive and transient neuromodulation. LIFU is an important advance and of great significance for brain-mapping efforts, diagnostics, and therapies in neuroscience and particularly promising for addiction therapy as it provides unprecedented non-surgical access to the brain regardless of depth.~Much lower intensities of focused ultrasound (LIFU) are used so that tissue damage does not occur, but neural activity can be modulated. LIFU utilizes acoustic energy at much lower levels to affect tissue by mechanical effects.
Study: NCT06235632

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Policy and Training Intervention
Description: The intervention is a combination of a policy training and access to an in-depth training program to teach marijuana vendors the skills needed to refuse intoxicated customers

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Usual and Customary Policy and Training (UC-PT) (Control) Condition
Description: The active control training that is already provided to marijuana vendors by the Oregon Liquor and Cannabis Commission
Study: NCT05189379

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Non-Alcoholic Odour
Description: A chemical used in fragrances and flavouring with a smell close to a nutty, buttery structure. Used as a 1:100 deionised water dilution.
Study: NCT06105398

Intervention type: OTHER
Intervention: clinical evaluation
Description: clinical evaluation tests

Intervention type: OTHER
Intervention: clinical evaluation
Description: clinical evaluation tests
Study: NCT06614764

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: AG (experimental Andiroba Gel)
Description: Prior to bleaching treatment with 35% hydrogen peroxide, the dental elements of the AG received application of the experimental desensitizing gel on the buccal surfaces of the central incisors, lateral incisors, canines and upper and lower premolars, with a rubber cup in an active way, for 10 minutes.
Study: NCT05189379

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Non-Alcoholic Odour
Description: A chemical used in fragrances and flavouring with a smell close to a nutty, buttery structure. Used as a 1:100 deionised water dilution.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Alcoholic Odour
Description: Alcoholic beverage beer / Alcoholic beverage red wine / Alcoholic beverage brandy / The type of the Alcoholic Odour intervention will be presented in a participant-preference basis.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Alcoholic Odour
Description: Alcoholic beverage beer / Alcoholic beverage red wine / Alcoholic beverage brandy / The type of the Alcoholic Odour intervention will be presented in a participant-preference basis.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Non-Alcoholic Images
Description: Images of non-alcoholic items, namely; broom, duster, clothing iron, lightbulb, mat, mulch, penlight, rack, rock, kitchen scissors, trough, vent are presented in parallel with the non-alcoholic odour

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Non-Alcoholic Images
Description: Images of non-alcoholic items, namely; broom, duster, clothing iron, lightbulb, mat, mulch, penlight, rack, rock, kitchen scissors, trough, vent are presented in parallel with the non-alcoholic odour

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Alcoholic Images
Description: Images of alcoholic items, namely, beer, wine, schnapps are presented in parallel with the alcoholic odour

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Alcoholic Images
Description: Images of alcoholic items, namely, beer, wine, schnapps are presented in parallel with the alcoholic odour
Study: NCT05986760

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: SPARK
Description: Functional Motor training
Study: NCT06614764

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: KF2G (Potassium nitrate gel)
Description: Prior to bleaching treatment with 35% hydrogen peroxide, the dental elements of the KF2G received application of the potassium nitrate gel on the buccal surfaces of the central incisors, lateral incisors, canines and upper and lower premolars, with a rubber cup in an active way, for 10 minutes.

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: PG (Placebo Gel)
Description: Prior to bleaching treatment with 35% hydrogen peroxide, the PG group received the application of a placebo gel (without active ingredient), under the same conditions described for the experimental gel.
Study: NCT05910814

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Sleep Deprivation (SD)
Description: Participants in the sleep deprivation group will spend a night awake, under the supervision of an investigator, at Croix-Rousse Hospital. The investigator will provide a list of activities to maintain the participant awake.
Study: NCT04791345

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Methylprednisone
Description: 12 mg of methylprednisone (3 pills of 4 mg each) administered orally in a single dose.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Methylprednisone
Description: 12 mg of methylprednisone (3 pills of 4 mg each) administered orally every 24 hours during 3 days.
Study: NCT05910814

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Sleep Deprivation (SD)
Description: Participants in the sleep deprivation group will spend a night awake, under the supervision of an investigator, at Croix-Rousse Hospital. The investigator will provide a list of activities to maintain the participant awake.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Normal Night (Night)
Description: Participants in the normal night group will spend one night sleeping in their own home.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Normal Night (Night)
Description: Participants in the normal night group will spend one night sleeping in their own home.
Study: NCT06615323

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Polyphonic Lullaby Group
Description: After discharge, mothers will be asked to play the Dandini Dandini Dastana lullaby by vocal artist Mircan Kaya, which they downloaded from the YouTube application, and listen to it from a distance of one meter (away from the baby's head to minimize radioactive effects) and by switching the phone to airplane mode just before sleep. In the event of active sleep (signs of sleep transition such as slowing down muscle movements and closing eyes), the polyphonic lullaby volume will be gradually reduced. The polyphonic lullaby will be played at a volume level of 55 decibels for the first 5 minutes after falling asleep, then reduced to 25 decibels and then turned off. In order to reduce the effects of confounding factors, mothers in the polyphonic lullaby group who use another assistive method (breastfeeding/rocking to sleep) to put their babies to sleep will be excluded from the study.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pish Pish Sound Group
Description: After discharge, mothers will be asked to turn on the Piş Piş sound downloaded from the YouTube application and listen to it from a distance of one meter (away from the baby's head to minimize radioactive effects) and by turning the phone to airplane mode just before sleep. In case of active sleep (signs of sleep transition such as slowing down muscle movements and closing eyes), the piş piş sound will be gradually reduced. The polyphonic lullaby played will be at a volume level of 55 decibels for the first 5 minutes after falling asleep, then reduced to 25 decibels and then turned off. In order to reduce the effect of confounding factors, mothers in the piş piş sound group who use another assistive method (breastfeeding/rocking to sleep) to put their babies to sleep will be excluded from the scope of the research.
Study: NCT05910814

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Normal Night (Night)
Description: Participants in the normal night group will spend one night sleeping in their own home.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Normal Night (Night)
Description: Participants in the normal night group will spend one night sleeping in their own home.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Physical Exercise (HIIE)
Description: Participants in the physical exercise group (i.e. IM+HIIE, PP+HIIE, SD+PP+HIIE) will start with a 2-minute warm-up on an ergometer cycle.~After the warm-up, they will perform 3 minutes of exercise at a workload customized to their maximal aerobic power (MAP) corresponding to 80 % their MAP and then rest actively for 2 minutes at 40 % of MAP. This cycle of 5 minutes will be repeated 3 times in row, resulting in a total of 17 minutes of physical exercise including the warm-up.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Physical Exercise (HIIE)
Description: Participants in the physical exercise group (i.e. IM+HIIE, PP+HIIE, SD+PP+HIIE) will start with a 2-minute warm-up on an ergometer cycle.~After the warm-up, they will perform 3 minutes of exercise at a workload customized to their maximal aerobic power (MAP) corresponding to 80 % their MAP and then rest actively for 2 minutes at 40 % of MAP. This cycle of 5 minutes will be repeated 3 times in row, resulting in a total of 17 minutes of physical exercise including the warm-up.
Study: NCT06563830

Intervention type: OTHER
Group type: OTHER
Intervention: educational application
Description: The content of the training to be applied to nurses will include: definition of MDRPI, etiology, prevalence and cost, staging, risk factors, nursing initiatives to be implemented to prevent MDRPI.
Study: NCT04976855

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: INDV-2000
Description: Capsule for oral administration

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: INDV-2000
Description: Capsule for oral administration

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: INDV-2000
Description: Capsule for oral administration

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: INDV-2000
Description: Capsule for oral administration

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: INDV-2000
Description: Capsule for oral administration

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Capsule for oral administration

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Capsule for oral administration
Study: NCT05910814

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Physical Exercise (HIIE)
Description: Participants in the physical exercise group (i.e. IM+HIIE, PP+HIIE, SD+PP+HIIE) will start with a 2-minute warm-up on an ergometer cycle.~After the warm-up, they will perform 3 minutes of exercise at a workload customized to their maximal aerobic power (MAP) corresponding to 80 % their MAP and then rest actively for 2 minutes at 40 % of MAP. This cycle of 5 minutes will be repeated 3 times in row, resulting in a total of 17 minutes of physical exercise including the warm-up.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Rest control
Description: Participants will watch a documentary during an equivalent time as the physical exercise (i.e. 17 minutes).
Study: NCT04791345

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Deflazacort
Description: 30 mg of deflazacort (1 pill) administered orally in a single dose.
Study: NCT05910814

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Rest control
Description: Participants will watch a documentary during an equivalent time as the physical exercise (i.e. 17 minutes).

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Rest control
Description: Participants will watch a documentary during an equivalent time as the physical exercise (i.e. 17 minutes).

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Motor imagery
Description: On the bimanual finger tapping task composed of 8 elements, the participant will be required to repeat the motor sequence mentally using MI (mental rehearsal of movement) during twelve blocks of 30 seconds. Participant will imagine performing the sequence as fast and accurately as possible without overt movement.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Motor imagery
Description: On the bimanual finger tapping task composed of 8 elements, the participant will be required to repeat the motor sequence mentally using MI (mental rehearsal of movement) during twelve blocks of 30 seconds. Participant will imagine performing the sequence as fast and accurately as possible without overt movement.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Physical Practice (PP)
Description: Participants will practice a bimanual sequential finger tapping task composed of 8 movements. Participant will be required to perform the sequence as fast and as accurately as possible during blocs of 30 s (i.e. twelve blocs during training).

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Physical Practice (PP)
Description: Participants will practice a bimanual sequential finger tapping task composed of 8 movements. Participant will be required to perform the sequence as fast and as accurately as possible during blocs of 30 s (i.e. twelve blocs during training).

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Physical Practice (PP)
Description: Participants will practice a bimanual sequential finger tapping task composed of 8 movements. Participant will be required to perform the sequence as fast and as accurately as possible during blocs of 30 s (i.e. twelve blocs during training).
Study: NCT04976855

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Capsule for oral administration

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Capsule for oral administration
Study: NCT05910814

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Physical Practice (PP)
Description: Participants will practice a bimanual sequential finger tapping task composed of 8 movements. Participant will be required to perform the sequence as fast and as accurately as possible during blocs of 30 s (i.e. twelve blocs during training).
Study: NCT05517993

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gui-Lu-Er-Xian-Jiao-Wan
Description: Gui-Lu-Er-Xian-Jiao-Wan (GLEXJW) is an ancient CHM formula, mainly originating from processed tortoise shells, antlers, Ginseng, and wolfberry.
Study: NCT04791345

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Description: 4 mg of dexamethasone (1 pill) administered orally in a single dose.
Study: NCT04976855

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SUBOXONE® sublingual film
Description: Administered either under the tongue (sublingual) or between the gum and cheek (buccal)
Study: NCT06644404

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: DWP16001 0.3mg
Description: 1 tablet, Orally, Once daily single dose

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: DWC202407 1,000mg
Description: 1 tablet, Orally, Twice daily

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: DWC202408 2mg
Description: 1 tablet, Orally, Once daily single dose
Study: NCT06644690

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: CO-OP with Creative Dance
Description: The CO-OP with Creative Dance intervention integrates the Cognitive Orientation to daily Occupational Performance (CO-OP) approach with structured creative dance sessions. The CO-OP approach focuses on improving cognitive and functional performance through goal-setting, problem-solving, and the use of metacognitive strategies. Creative dance sessions involve simple, rhythmic movements aimed at enhancing motor coordination, memory, and attention. This intervention is administered three times per week for 60 minutes over 8 weeks. The sessions alternate between CO-OP activities and creative dance exercises.
Study: NCT06612606

Intervention type: OTHER
Intervention: observational study
Description: This was an observational study with no intervention.

Intervention type: OTHER
Intervention: observational study
Description: This was an observational study with no intervention.